Compare AdaptHealth Corp (AHCO) vs ThredUp Inc (TDUP) Price & Performance

AdaptHealth (AHCO) trades at $5.77, up 2.12% today, but faces a bearish technical trend with recent earnings misses and a net loss of $70.79 million in 2025. Revenue grew to $3.24 billion, yet profitability remains challenged with a negative net margin. The company is refocusing on sleep and respiratory care after selling its diabetes unit, but faces multiple securities fraud investigations following a significant Q2 2026 earnings shortfall.

The outlook is cautious; while analyst consensus is bullish with a $11.00 price target, near-term risks from legal probes, execution missteps, and margin pressure outweigh potential upside. Investor sentiment is negative due to guidance cuts and operational challenges, making the stock high-risk despite its low valuation multiples.

ThredUp (TDUP) trades at $3.17, up 0.96% on the day, but remains under pressure after a significant Q2 2026 earnings miss and lowered full-year revenue guidance. The stock's technical picture is bearish, while fundamentals show improving revenue growth but persistent losses. Recent news highlights an ongoing securities investigation related to the guidance revision, contributing to negative sentiment.

The outlook is cautious. While analyst consensus is technically 'Buy' (57% of ratings), recent operational setbacks and the stock's sharp decline post-earnings suggest significant near-term risk. The primary opportunity lies in the company's high gross margins and active buyer growth, but profitability remains elusive and investor confidence is fragile.